Andreas Barner
Directeur Général chez Boehringer Ingelheim GmbH
Profil
Andreas Barner is currently the Chairman at Boehringer Ingelheim RCV GmbH & Co. KG, Co-Managing Director at Boehringer Ingelheim GmbH, and Director at Carl-Zeiss-Stiftung.
He previously held positions as Chairman at Boehringer Ingelheim AB, Advisor at NGN Capital LLC, and Principal at BASF Performance Products Ltd.
(United Kingdom).
Dr. Barner holds a doctorate degree from the University of Freiburg and the Swiss Federal Institute of Technology.
Postes actifs de Andreas Barner
| Sociétés | Poste | Début |
|---|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Directeur Général | - |
Boehringer Ingelheim RCV GmbH & Co. KG
 Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Président | - |
Carl-Zeiss-Stiftung
 Carl-Zeiss-Stiftung Investment Trusts/Mutual FundsMiscellaneous Carl-Zeiss-Stiftung is a company-linked foundation. The firm manages the companies Carl Zeiss AG and SCHOTT AG, which specialize in optics and optoelectronics, as well as specialty glass and glass-ceramics. It also promotes the sciences, engineering, and mathematics at universities through dividends from the Foundation firms. The company was founded by Ernst Abbe on May 19, 1889 and is headquartered in Stuttgart, Germany. | Directeur/Membre du Conseil | - |
Anciens postes connus de Andreas Barner
| Sociétés | Poste | Fin |
|---|---|---|
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Directeur/Membre du Conseil | 31/10/2007 |
Boehringer Ingelheim AB
 Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Président | - |
BASF Performance Products Ltd. (United Kingdom)
 BASF Performance Products Ltd. (United Kingdom) Chemicals: SpecialtyProcess Industries Basf Performance Products Ltd. manufactures chemical products. It offers dyes and pigments, plastics, and other inorganic basic chemicals. The company was founded on September 12, 1996 and is headquartered in Cheadle, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Andreas Barner
| University of Freiburg | Doctorate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
NGN Capital LLC
NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Finance |
BASF Performance Products Ltd. (United Kingdom)
BASF Performance Products Ltd. (United Kingdom) Chemicals: SpecialtyProcess Industries Basf Performance Products Ltd. manufactures chemical products. It offers dyes and pigments, plastics, and other inorganic basic chemicals. The company was founded on September 12, 1996 and is headquartered in Cheadle, the United Kingdom. | Process Industries |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Boehringer Ingelheim AB
Boehringer Ingelheim AB Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim AB develops, produces, markets and sells pharmaceutical products. The firm also provides research, development, manufacturing and marketing services in the therapeutic field of human and veterinary medicine. The company was founded in 1967 is headquartered in Stockholm, Germany. | Health Technology |
Boehringer Ingelheim RCV GmbH & Co. KG
Boehringer Ingelheim RCV GmbH & Co. KG BiotechnologyHealth Technology Boehringer Ingelheim RCV GmbH & Co. KG develops and supplies biotherapeutic proteins, plasmid DNA and antibody fragments. The company was founded in 1885 by Albert Boehringer and is headquartered in Vienna, Austria. | Health Technology |
Carl-Zeiss-Stiftung
Carl-Zeiss-Stiftung Investment Trusts/Mutual FundsMiscellaneous Carl-Zeiss-Stiftung is a company-linked foundation. The firm manages the companies Carl Zeiss AG and SCHOTT AG, which specialize in optics and optoelectronics, as well as specialty glass and glass-ceramics. It also promotes the sciences, engineering, and mathematics at universities through dividends from the Foundation firms. The company was founded by Ernst Abbe on May 19, 1889 and is headquartered in Stuttgart, Germany. | Miscellaneous |